Caroline M. Loewy

Insider Reports History

Entity
Individual
Location
300 Elliott Ave West, Suite 500, Seattle, Washington
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caroline M. Loewy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PHOENIX BIOTECH ACQUISITION CORP. Director Class A Common Stock 5.83K $58.3K $10.00 Feb 14, 2024 Direct
eFFECTOR Therapeutics, Inc. Director Common Stock 9.05K $5.49K $0.61 Sep 9, 2023 Direct
Aptose Biosciences Inc. Former Director Director Stock Option (Right to Buy) 50K Jan 18, 2022 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 3.75K May 19, 2023 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 Jun 13, 2024 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 May 19, 2023 Direct
ZOGENIX, INC. Director Stock Option (Right to Buy) 0 $26.09 Mar 7, 2022 Direct

Insider Reports Filed by Caroline M. Loewy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EFTR eFFECTOR Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
CBAY CymaBay Therapeutics, Inc. Mar 22, 2024 10 $0 4 Mar 22, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 19, 2024 1 $0 4 Feb 21, 2024 Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 1 $0 4 Feb 16, 2024 Director
CBAY CymaBay Therapeutics, Inc. Jan 24, 2024 1 $0 4 Jan 26, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Sep 9, 2023 1 $0 4 Sep 11, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Sep 9, 2023 0 $0 3 Sep 11, 2023 Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2023 2 $0 4 May 19, 2023 Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Director
APTO Aptose Biosciences Inc. May 31, 2022 0 $0 4 Jun 15, 2022 Former Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2022 2 $0 4 May 20, 2022 Director
ZGNX ZOGENIX, INC. Mar 7, 2022 2 $0 4 Mar 9, 2022 Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Director
APTO Aptose Biosciences Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 8, 2021 1 $0 4 Oct 12, 2021 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
PHASQ PhaseBio Pharmaceuticals Inc Jun 3, 2021 1 $0 4 Jun 4, 2021 Director
ZGNX ZOGENIX, INC. May 27, 2021 1 $0 4 May 28, 2021 Director